Author
Listed:
- Damien Gerald
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School
ImClone Systems (a wholly owned subsidiary of Eli Lilly and Company))
- Irit Adini
(Children’s Hospital, Harvard Medical School)
- Sharon Shechter
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Carole Perruzzi
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School
ImClone Systems (a wholly owned subsidiary of Eli Lilly and Company))
- Joseph Varnau
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Benjamin Hopkins
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Shiva Kazerounian
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Peter Kurschat
(Children’s Hospital, Harvard Medical School)
- Stephanie Blachon
(Hybrigenics Services)
- Santosh Khedkar
(ImClone Systems (a wholly owned subsidiary of Eli Lilly and Company)
Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Mandrita Bagchi
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- David Sherris
(VasculoMedics Inc.)
- George C. Prendergast
(Anatomy and Cell Biology, Kimmel Cancer Center, Jefferson Medical School, Thomas Jefferson University)
- Michael Klagsbrun
(Children’s Hospital, Harvard Medical School)
- Heidi Stuhlmann
(Weill Cornell Medical College)
- Alan C. Rigby
(ImClone Systems (a wholly owned subsidiary of Eli Lilly and Company)
Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Janice A. Nagy
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Laura E. Benjamin
(Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School
ImClone Systems (a wholly owned subsidiary of Eli Lilly and Company))
Abstract
Mechanisms governing the distinct temporal dynamics that characterize post-natal angiogenesis and lymphangiogenesis elicited by cutaneous wounds and inflammation remain unclear. RhoB, a stress-induced small GTPase, modulates cellular responses to growth factors, genotoxic stress and neoplastic transformation. Here we show, using RhoB null mice, that loss of RhoB decreases pathological angiogenesis in the ischaemic retina and reduces angiogenesis in response to cutaneous wounding, but enhances lymphangiogenesis following both dermal wounding and inflammatory challenge. We link these unique and opposing roles of RhoB in blood versus lymphatic vasculatures to the RhoB-mediated differential regulation of sprouting and proliferation in primary human blood versus lymphatic endothelial cells. We demonstrate that nuclear RhoB-GTP controls expression of distinct gene sets in each endothelial lineage by regulating VEZF1-mediated transcription. Finally, we identify a small-molecule inhibitor of VEZF1–DNA interaction that recapitulates RhoB loss in ischaemic retinopathy. Our findings establish the first intra-endothelial molecular pathway governing the phased response of angiogenesis and lymphangiogenesis following injury.
Suggested Citation
Damien Gerald & Irit Adini & Sharon Shechter & Carole Perruzzi & Joseph Varnau & Benjamin Hopkins & Shiva Kazerounian & Peter Kurschat & Stephanie Blachon & Santosh Khedkar & Mandrita Bagchi & David S, 2013.
"RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription,"
Nature Communications, Nature, vol. 4(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3824
DOI: 10.1038/ncomms3824
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3824. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.